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Predictive measures of vascular access thrombosis: A prospective
study. Malfunction of permanent vascular accesses remains a cause of
frequent and costly morbidity in patients receiving chronic hemodialysis(CHD). Several recommendations for routine monitoring of these perma-
nent vascular accesses for incipient failure have been proposed. In this
study, multiple indicators of incipient vascular access dysfunction, includ-
ing "venous" and "arterial" pressures at serial blood flows (200 mI/mm,
300 mI/mm, and 400 mI/mm), percent urea recirculation, Doppler ultra-
sound, and access blood flow by ultrasound dilution technique were
simultaneously evaluated in a total of 220 vascular accesses in 170 chronic
hemodialysis patients in two separate study periods (6 months apart). The
rate of thrombosis was determined within the subsequent 12 weeks of each
study period to assess the short-term predictive power of access throm-
bosis. During the period of follow-up, there were 34 thrombotic events in
172 polytetrafluoroethylene (PTFE) grafts and only one thrombotic event
in 48 arterio-venous fistulas (AVF). Therefore, the statistical analysis was
limited to the PTFE grafts. When grafts with thromboses were compared
to those without thrombosis by univariate analysis, access blood flow
measured either by ultrasound dilution technique (875 426 mI/mm with
thrombosis vs. 1193 677 mI/mm without thrombosis, P = 0.001) or by
Doppler ultrasound (762 420 mI/mm with thrombosis vs. 1171 657
mI/mm without thrombosis, P = 0.001) were significantly different in the
two groups. There was good correlation (r = 0.79, P = 0.0001) between
the blood flows determined by both techniques. The grade of stenosis
determined by ultrasound was also a statistically significant predictor (P =
0.02). "Venous" and "arterial" pressures were numerically similar and
were not statistically different between the accesses that did and those that
did not thrombose. When multivariate analysis was used, there was a
significantly increased risk of thrombosis only with decreasing access blood
flow determined by ultrasound dilution techniques after adjusting for
other confounding variables. When the average blood flow of all grafts
(1134 mI/mm) is considered as the reference access blood flow (relative
risk of 1.0), the relative risk of a PTFE thrombotic event within the
subsequent 12 weeks was 1.23 at a blood flow 950 mI/mm, 1.67 at a blood
flow of 650 mI/mm and to 2.39 at a blood flow of 300 mI/mm. In summary,
access blood flow measured by either Dilution or Doppler is a reliable
indicator of subsequent short-term thrombosis risk. Other proposed
methods of evaluating access dysfunction were not useful in our patients.
If simple to use, cost-effective devices to measure dialysis access blood
flow become readily available, the measurement of access blood flow will
likely become the method of choice for screening of PTFE vascular access
dysfunction in hemodialysis patients.
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Malfunction of permanent vascular accesses, which include
native vein fistulae (AVF) and polytetrafluoroethylene (PTFE)
grafts, remains a cause of frequent and costly morbidity in patients
receiving chronic hemodialysis (CHD). The direct costs of hospi-
talization attributed to vascular access dysfunction are estimated
to be in excess of 500 million dollars annually, and when costs for
outpatient evaluation and treatment are included this number
may approach one billion dollars [1]. Monetary costs aside,
patients with access thrombosis are also exposed to increased risks
associated with the use of temporary venous catheter placemeni
including a higher incidence of infections and a lower dose of
dialysis [2], the use of chemical and/or mechanical thrombolysis.
increased rate of hospitalization and loss of potential sites for
future new accesses [3].
Thrombosis of permanent PTFE grafts is the most common
cause of access dysfunction and over two-thirds of thrombosed
PTFE grafts will have a stenosis at the venous anastamosis at the
time of the thrombotic episode [4—6]. A number of non-random-
ized studies have shown that prophylactic repair of accesses at
risk, either surgically or with interventional angioplasty, prior to
thrombosis significantly prolongs the useful life of the access and
reduces the rate of future thrombosis when compared to accesses
repaired surgically after a thrombotic event [7—9]. These findings
have led to recommendations for routine monitoring of perma-
nent vascular accesses using an array of indicators that purport to
serve as predictors of future access dysfunction [10]. In general,
these indicators are indirect surrogates for the detection of
stenosis at the distal venous anastamosis and commonly include:
elevated efferent "venous" pressures measured during the first ten
minutes of each dialysis session at specified dialyzer blood flows
(Qb) [11], increased access recirculation, unexplained decrements
in the blood urea reduction ratio (URR) [12], unexpected in-
creases in urea volume of distribution, or a reduction in blood
flow through the access measured with Doppler ultrasound [13—
15]. Uncontrolled or retrospective studies have also shown that
the presence of radiographically demonstrable access stenosis
either by gray scale ultrasound or venography correlate with
future thrombosis [15, 16]. Recently, methods which directly
measure access function have been reported and include elevated
static measurements of intra-access venous pressure at zero blood
flow [7, 17] and low access blood flow using the ultrasound velocity
dilution technique [18].
Although some of these measures have been shown to predict
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Gender (M/F)
Race
Age years
Cause of ESRD
36% Diabetes
38% Hypertension
5% Glomerulonephritis
2% PCKD
19% Unknown
Location of access
51% Left lower arm
23% Left upper arm
13% Right lower arm
10% Right upper arm
3% Lower extremity (excluded from
analysis)
PTFE configuration
Loop
Straight
_________________
eventual access thrombosis, to date there have been no large
prospective trials which have examined simultaneously the array
of indicators of access dysfunction using access thrombosis as the
primary endpoint. Furthermore, the reported specificity and
sensitivity of individual indicators of access dysfunction have
varied in the literature. To evaluate which of the indicators of
access dysfunction best predicts short-term future access throm-
bosis and to better define sensitivity and specificity of these
measurements, we performed a three-center prospective study of
various potential predictors of vascular access viability.
METHODS
Patient characteristics
One hundred and seventy patients at three regional dialysis
centers were evaluated. Characteristics of the patient population
are depicted in Table 1.
Study design
Permanent vascular accesses included for study were being
actively used for chronic hemodialysis three times a week and
were at least four weeks old for PTFE and 12 weeks old for AVF.
Baseline characteristics collected for all accesses studied included
type of vascular access (AVF vs. PTFE or other synthetic graft),
anatomic location (left vs. right arm; upper vs. lower arm),
configuration of PTFE grafts (loop vs. straight) and initial date of
surgical creation.
The study consisted of the measurement of several indicators
(vide infra) simultaneously over two separate time periods. These
two time periods were six months apart. Each series of measure-
ments was followed by an observation period of three months
thereafter for each of the accesses studied in order to detect the
rate of thrombosis in those accesses, in the absence of any planned
intervention. Since the study was done during two separate time
periods, 50 patients were evaluated twice during the study and a
total of 220 accesses were studied.
All accesses were available for follow up for the three month
period except for patients censored for renal transplantation,
repair of the access prior to a thrombotic event, change to
peritoneal dialysis or death.
METHODS
Each vascular access was screened at the beginning of the study
with regard to clinical parameters of access function. These
baseline screening measurements were divided into three catego-
ries broadly categorized as: hemodynamic measures of access
function (venous pressure, arterial pressure and access recir-
culation), access blood flow determined by ultrasound velocity
dilution technique, and direct access imaging with Doppler ultra-
sound. A brief description of each of the methods of measure-
ments are listed below.
Hemodynamic measures of access function
All such measurements for an individual access were obtained
within the first 30 minutes of the same dialysis session and all
accesses were cannulated using 15 gauge needles. The following
measurements were obtained at baseline of the study:
(1.) Venous pressures (mm Hg) measured at the distal (post
dialyzer) blood drip chamber consecutively at Qb of 200, 300, and
400 ml/min. Approximately one minute was allowed between each
measurement after the change in Qb. Each measurement was
taken from the dialysis machine venous pressure monitor and was
limited to a value from the readout available on the dialysis
equipment (Fresenius 2008H, Walnut Creek, CA, USA). The
range of measurements available for venous pressures was —80
mm Hg to 500 mm Hg in increments of 20 mm Hg.
(2.) Arterial pressures (mm Hg) measured at the proximal
(pre-blood pump) blood drip chamber at Qb of 200, 300, and 400
mi/mm. Since the arterial pressure monitor was before the blood
pump, these readings were usually "negative." Approximately one
minute was allowed between measurements after the change in
Qb. Each measurement was taken from the dialysis machine
arterial pressure monitor and was limited to a value from the
readout available on the dialysis equipment. The range of mea-
surements available for arterial pressures was 280 mm Hg to —300
mm Hg in increments of 20 mm Hg.
Each venous and arterial pressure reading was compared to
those routinely obtained by the staff over the previous three
hemodialysis sessions and any outlier reading was repeated at the
next hemodialysis session. In addition, venous and arterial pres-
sures as well as percent urea recirculation were obtained sequen-
tially every month for a period of six months.
(3.) Percent recirculation was performed using blood urea
nitrogen (BUN) as the indicator, with the "slow flow" method
[12]. Calculation was performed using the equation:
percent recirculation = 100 X [(a3 — al)/(a3 — a2)]
where al is the concentration of BUN drawn from the arterial
blood line port at Qb of 350 mI/mm, a2 is the concentration of
BUN simultaneously drawn from the venous blood line port at Qb
of 350 mI/mm, and a3 is the concentration of BUN drawn from
the arterial blood line port within 15 to 30 seconds after the Qb
was reduced to 50 ml/min. A dialyzer blood flow of 350 ml/min
was chosen to improve sensitivity, as recent reports have shown
that access recirculation is absent or minimally present at low
dialyzer blood flows unless severe reduction of access blood flow
is present [19]. Dialyzer blood flow of 350 ml/min was the highest
blood flow that was achievable in all studied accesses. Percent
access recirculations that were negative (al > a3) were reported
as zero.
Table 1. Patient information
36% M/64% F
62% W/38% non-white
66.4 10.4
62 (89.9%)
7(10.1%)
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Access blood flow by ultrasound velocity dilution technique
All vascular accesses had direct measurement of access blood
flow determined using the ultrasound velocity dilution (Dilution)
technique (Transonic Systems, Inc., Ithaca, NY, USA). This
technique has been previously described and validated [18]. The
dilution technique uses two reusable clip sensors, one on the
arterial blood line and one on the venous blood line, which are
linked to a computer. For the measurement of access blood flow,
dialyzer blood lines are reversed and a temporary recirculation is
created. Then, 10 ml of isotonic saline is quickly injected into the
venous line. The access blood flow is measured using the changes
in doppler velocity through the blood lines as the blood concen-
tration changes with respect to actual dialyzer blood flow using the
following formula:
Qac = Qb * (1/Kr — 1)
where Qac is the access flow, Qb is the dialyzer blood flow, Kr is
the recirculation coefficient; and Kr is equal to Smix/Sven, where
Smix and Sven are the areas under the dilution curves generated
by the arterial and venous sensors, respectively. This technique
was validated using bovine blood and two calibrated pumps for
bovine access blood flow (300 to 1500 ml/min) and dialyzer flow
(100 to 400 ml/min). A more detailed explanation of the method
can be found elsewhere [181.
Access blood flow was determined as the average of two
separate measurements taken approximately 5 to 10 minutes
apart during the same dialysis session; these measurements were
also completed within the first 30 minutes of the session. Because
of the time associated with each test, these measurements were all
completed within two weeks of the time that the other measures
of access dysfunction were completed.
Ultrasound with Doppler
Evaluation of vascular accesses was performed using an ultra-
sound unit with color and spectral flow Doppler capability (Acu-
son 128 x PlO). The vascular accesses were examined with a 7.5
MHZ transducer in the longitudinal and transverse planes with
and without color Doppler, from feeding artery across the prox-
imal arterial anastamosis, through the entire graft or fistula, and
into the distal vein as far to the central venous system (that is,
subclavian or brachial vein) as was technically possible. Each
stenosis was graded with regard to: (1) location (proximal "arte-
rial" anastamosis, intra-graft or intra-vein, venous anastamosis,
distal vein, and central vein if visualized); (2) percent stenosis,
determined by the ratio of the minimal intraluminal cross-
sectional area at the stenosis to the intraluminal cross-sectional
area of the nearby normal segment calculated by equipment
software. These calculations were than classified into four grades
(Grade I stenosis less than 30%, Grade II = stenosis 30 to 50%,
Grade III = stenosis 51 to 70%, Grade IV = stenosis greater than
70%). Access volume flow was calculated using the time velocity
integral of a midstream spectrum obtained from a normal area of
the access. Cross-sectional area of the graft was measured and
volume flow was calculated by equipment software. Measure-
ments were made at a point free of wall irregularities where flow
was non-turbulent. Doppler angle was maintained less than or
equal to 60 degrees for all velocity measurements. Scans were
performed and videotaped by a vascular ultrasound technologist
(Medical Imaging Resources, Kiioxville, TN, USA) and the tapes
were reviewed by a radiologist.
A total of 89 accesses were evaluated by Doppler for the
variables mentioned above. However, only 48 out of 89 accesses
had complete assessment of grade of stenosis and only those
accesses were used in the analysis of grade of stenosis.
Rates of thromboses
All accesses were monitored for three months following each
study period for the occurrence of a clinical thrombosis. Patients
were censored from the final analysis if they underwent renal
transplantation, converted to peritoneal dialysis, had their access
removed for infection or non-thrombotic complication or died
before the end of the three month follow-up period. The occur-
rence of elective access angioplasty or surgical revision without a
clinical thrombotic event (only 2 accesses) was also used as a
censoring event.
Statistical analysis
The Repeated Measures Analysis of Variance Mixed effect
model was used to determine the relationship between continuous
parameters, such as access blood flow and thrombosis in PTFE
grafts. To determine the best predictors for thrombosis in PTFE
grafts, the Generalized Estimating Equation (GEE) method
statistical procedure for longitudinal data analysis with multiple
observable vectors for the same subject [20, 211 was used to adjust
the intra-correlation effect for the patients who had multiple
thrombosis in PTFE grafts. This procedure is a repeated measures
analysis for correlated dichotomous outcomes (thrombosis vs. no
thrombosis) and a set of predictors.
All tests of significance were two-sided, and differences were
considered statistically significant when the P value < 0.05. All
data were expressed as means SD. The SAS version 6.12 and
SAS GEE macro were used for data analyses.
RESULTS
A total of 220 accesses in 170 patients were evaluated during
the study period. One hundred and seventy-two accesses (78%)
were PTFE grafts and 48 accesses (22%) were AVF (22%).
During the study period, only one of the 48 arterio-venous fistulas
(2%) developed thrombosis, which was a significantly lower rate
of thrombosis than PTFE grafts (20%). Since the number of
thromboses in AVF was insufficient to derive any statistical and/or
clinical conclusions, further analysis of the data were restricted
only to 172 the PTFE grafts.
Table 2 depicts general descriptive statistics of the 172 PTFE
grafts followed in the study according to the variables obtained at
the time of the study. During the two study periods (each 14 weeks
long: 2 weeks of data collection followed by 12 weeks of observa-
tion), a total of 34 thrombotic events were observed in these
PTFE grafts (0.20 event/access). Three events were recurrent
thrombosis in the same accesses. Table 3 compares the charac-
teristics of the accesses that thrombosed in the 12 weeks following
the initial data collection to those that did not. Access blood flow
measured by Dilution (875 426 ml/min in accesses that throm-
hosed vs. 1193 677 ml/min in accesses that did not thrombose,
P = 0.001) was significantly different in the two groups. The
hemodynamic measures (venous and arterial pressures at 3 dif-
ferent blood flows and percent urea recireulation) were not
statistically different between the thrombosis and no thrombosis
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groups. Specifically, the venous pressure measurements were 98
97 mm Hg versus 97 25 mm Hg at a dialyzer blood flow of 200
ml/min, 147 32 mm Hg versus 148 33 mm Hg at a dialyzer
blood flow of 300 ml/min and 207 33 mm Hg versus 203 34
mm Hg at a dialyzer blood flow of 400 mi/mm for PTFE grafts that
thrombosed versus those did not, respectively. Similarly, mean
percent urea recirculation was not different between the two
groups (4.9 4.8 vs. 5,2 4.1, respectively). Finally, arterial
pressures at dialyzer blood flows of 200, 300 and 400 ml/min were
also not significantly different between accesses that thrombosed
versus those that did not.
Doppler ultrasound
Access blood flows by Doppler were available in 87 PTFE
grafts. Figure 1 depicts the correlation of blood flows by Dilution
and Doppler. There was a statistically significant correlation with
a correlation coefficient of r = 0.79 (P = 0.0001). Univariate
analysis for access blood flows determined by Doppler ultrasound
for grafts that thrombosed versus those that did not thrombose
was also statistically significant (762 420 mI/mm vs. 1171 657
mi/mm respectively, P = 0.001). When the data were further
analyzed for the complete Doppler ultrasound measurements
available in 48 PTFE grafts, the grade of stenosis was significantly
different for PTFE grafts that thrombosed versus those that did
not (Fig. 2; P = 0.02 by Chi-square test). However, the grade of
Fig. 2. Percent of PTFE access thrombosis for each grade of stenosis
determined by Doppler ultrasound (N = 12 for grade I, 14 for grade II, 12
for grade III and 10 for grade IV).
stenosis did not significantly correlate with the access blood flow
when measured by either the Dilution or Doppler techniques.
We also analyzed the results of the measured vascular access
dysfunction variables according to quartiles. Figure 3 shows access
blood flows determined by ultrasound Dilution divided into
quartiles in PTFE grafts that thrombosed versus those that did
not. In the lowest blood flow quartile by Dilution (less than 710
mI/mm), 11 out of 44 grafts thrombosed (25%) whereas in the
highest quartile (higher than 1395 mi/mm), only 4 out of 43
(9.3%) PTFE grafts thrombosed. This trend of increasing inci-
dence of thrombosis with decreasing blood flow in the access was
statistically significant by linear regression analysis. A similar
comparison was done for other measured variables. Figure 4
depicts the quartiles of venous pressures at Qb of 200 mi/mm and
percent urea recirculation. There were no statistically significant
trends in the incidence of thrombosis with either increasing
venous pressure or percent urea recirculation.
The cause of renal disease, the location of the access, the
configuration of the PTFE (straight vs. loop), use of antithrom-
botic agents and patient demographics were also found not to be
significantly different in the group that thrombosed versus those
Table 2. Values for PTFE grafts at the time of screening
measurements of study parameters
Venous pressure mm Hg
Qb @ 200 ml/min 97 26 (40—180)
Qb @ 300 mI/mm 148 32 (80—280)
Oh @ 400 mI/mm 203 34 (120—300)
Arterial pressure mm Hg
Qb @ 200 ml/min —40 26 (—120 to 20)
Oh @ 300 ml/min —101 32 (—220 to —20)
Oh @400 mI/mm —177 40 (—300 to —100)
% Recirculation Ob @ 350 mI/mm 4.9 4.7% (0—33)
Blood flow (Dilution) ml/min 1135 650 (39—3621)
Blood flow (Doppler) ml/min 1003 725 (176—3794)
Data are mean SD; (range is in parentheses).
Abbreviation PTFE is polytetrafluroethylene.
Table 3. Comparison of demographic and mean (± SD) study
parameter values for accesses that thrombosed and that did not
thrombose
4000
3000
2000
1000
0
Access blood flow by dilution
Fig. 1. Correlation of access blood flow measurements by Doppler duplex
ultrasound (Doppler) and ultrasound dilution (Dilution) techniques.
60%
50%
U,
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Thrombosis No thrombosis
Sex % male/female 36/64 43/56
Race % AA/White 48/52 54/46
Access flow (Dilution) mI/mm 875 426 1193 677
Access flow (Doppler) ml/min 762 420 1171 657
Venous pressure mm Hg
Oh @ 200 ml/min 98 97 97 25
Qb @ 300 ml/min 147 32 148 33
Ob @ 400 mI/mm 207 33 203 34
Arterial pressure mm Hg
Oh @ 200 ml/min —39 27 —42 21
Ob @300 mI/mm —100 22 —101 34
Ob@400m1/min —182±34 —176±41
Percent recirculation 4.9 4.8 5.2 4.1
P = 0.001 versus no thrombosis
I II Ill l''
1660 May et al: Vascular access thrombosis
50%
45%
40%
. 35%
2 30%
25%
20%
15%
10%
5%
I0/LI /0
that did not thrombose using univariate analysis. Finally, there
was no difference in average venous pressures readings over a
period of up to six months in accesses that thrombosed versus
those that did not thrombose.
Multivariate analysis
We further analyzed our data by multivariate analysis to
identify the best predictor of thrombosis in PTFE grafts after
adjustment for other factors. Consistent with the univariate
analysis, the blood flow by Dilution was the best predictor of
thrombosis within the subsequent three months. Multivariate
analysis showed a significantly increasing risk of thrombosis with
decreasing access blood flow after adjusting for other confounding
variables. Figure 5 depicts a schematic diagram of the risk ratio to
incremental changes in blood flow by 50 ml/min increments.
When the average blood flow of all grafts (1134 mI/mm) was
considered as the reference access blood flow (relative risk of 1.0),
the relative risk of a PTFE thrombotic event within the next 12
weeks was 1.23 at a blood flow 950 ml/min and 1.51 at a blood flow
750 mi/mm. The relative risk of access thrombosis was further
exponentially increased to 1.67 at a blood flow of 650 mI/mm and
to 2.39 at a blood flow of 300 ml/min.
In contrast to access blood flow by Dilution technique, none of
the other variables that were followed in the study were found to
significantly predict access thrombosis in our patient population in
this multivariate analysis. Blood flow by Doppler ultrasound also
lost its statistical significance in multivariate analysis. However,
the sample size on ultrasound Doppler data may have been too
small to derive any statistical conclusions by multivariate analysis
(N = 48).
DISCUSSION
Malfunction of permanent vascular access remains a leading
cause of both morbidity and expense for patients with end-stage
renal disease on chronic maintenance hemodialysis therapy [2]. It
is also a potentially reversible cause of morbidity. The rapid
growth of end-stage renal failure programs in the United States
and worldwide has been accompanied by a tremendous increase in
hemodialysis vascular access morbidity. Recent estimates indicate
that in the USA alone, Medicare will pay for more than 90,000
hospital admissions for vascular access-related problems in 1995
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with an estimated annual cost greater than 1 billion dollars per
year [1]. In addition to financial issues, vascular access-related
morbidity can contribute significantly to alterations in the quality
of life as well as the dose of delivered dialysis [221.
While the autogenous arteriovenous fistula remains the dialysis
access of choice, PTFE grafts account for the large majority of
permanent accesses. Recent data drawn from the United States
Renal Data System 1986-1987 Case Mix Severity and the USRDS
1990 Case Mix Adequacy special studies indicate that the use of
PTFE grafts for permanent access is increasing in the United
States over time [23]. Further studies using the standard analysis
file of the USRDS Case Mix Adequacy Study demonstrate the
superiority of native arteriovenous fistulae to PTFE grafts in all
age groups, even after adjusting for patient comorbidity [23].
Most PTFE grafts fail because of the development of myointi-
mal hyperplasia at or distal to the venous anastamosis [24, 25].
The resulting stenosis from the intimal hyperplastic lesions leads
to hemodynamic changes, including changes in access outflow
pressure and resistance, as well as access blood flow. A severe
venous stenosis can also result in recirculation of blood back to
the arterial side of the dialysis access [121. In recent years,
investigative efforts have focused on identifying elevated venous
pressure [11], increased urea recirculation [191, increased vascular
outflow resistance [26—30] or decreased vascular flow [101 as
19%
<710 710—1010 1010—1395 >1395
A
B
Access blood flow, mi/mm
Fig. 3. Percent of PTFE access thrombosis for each quartile of access
blood flow determined by ultrasound dilution technique (P < 0.01 by
regression analysis).
8% U /0
80—1 00 100—120
Venous pressure, mm Hg
22%
.I /0
—
19% 18%
I
>7%<0.5% 0.5%—4.5% 4.5%—7%
% Urea recirculation
Fig. 4. Percent of PTFE access thrombosis for each quartile of venous
pressure measurements at 200 mI/mm dialyzer blood flow (A). Percent of
PTFE access thrombosis for each quartile of percent urea recirculation
(B).
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screening tests for the detection of vascular access dysfunction
prior to the development of thrombosis. Furthermore, several
prospective (albeit non-randomized) studies have demonstrated
that early detection of vascular access dysfunction in conjunction
with either angioplasty or surgical revision results in prolongation
of the functional life of the vascular access for dialysis patients [7,
9, 11].
The rationale for the present study was to prospectively evalu-
ate several of the available screening tools for the detection of
vascular access dysfunction in order to evaluate their relative
efficacy in predicting early vascular access thrombosis. To our
knowledge, this is the first study to prospectively compare multi-
ple vascular access screening techniques simultaneously in two
large dialysis facilities reflective of the US chronic hemodialysis
patient population. Our goal was to focus on the short-term (12
weeks) thrombosis rate with the rationale that this would be most
useful to clinicians; therefore, the three month thrombosis rate
was the primary end point of this study.
The results of this study clearly support the emerging concept
that dialysis access blood flow is the best predictor of incipient
thrombosis, particularly in hemodialysis patients with PTFE
grafts. Indeed, in this study multivariate analysis showed that only
vascular access blood flow proved to be an important predictor of
early thrombosis, both in univariate and multivariate analyses. In
the subset of patients who had measurements of vascular access
blood flow both by the dilution technique and by Doppler
ultrasound techniques, both proved to be predictive of incipient
graft thrombosis and there was a good correlation between these
techniques (Fig. 1). These results are supported by other single
center and/or preliminary studies that have demonstrated utility
of access flow using either technique to predict thrombosis
[26—281.
Because of the limited number of blood flow estimation by
Doppler ultrasound measurements, blood flow by this technique
was not a statistically significant predictor in multivariate analysis
that included the Dilution blood flow determined. However, it was
a statistically significant predictor in univariate analysis; in addi-
tion, the grade of stenosis was also a statistically significant
predictor in the univariate analysis, with a 57% rate of thrombosis
in accesses with greater than 70% stenosis (grade IV).
In contrast to several previous studies [11], in this study we did
not find that measurement of venous pressure was a predictor of
early graft thrombosis. The reasons for the discrepancy between
this study and previous studies are not clear. However, it should
be noted that Besarab and Samarapungavan have recently em-
phasized the indirect nature of dynamic measures of venous
pressure [29]. Under dynamic conditions, venous pressure can be
affected by needle size, needle placement, and is affected by
pressure within the dialysis circuit not related to the dialysis
access, including dialyzer blood flow-dependent pressure gradi-
ents through the external tubing and needle. One other study has
also found little predictive power in dynamic venous pressure
measurements for predicting PTFE graft thrombosis [30]. In
contrast, direct measurement of intra-access pressure under static
conditions has a high correlation with measurements of access
flow and appears to be an excellent predictor of graft thrombosis
[7], but requires special equipment.
In this study, we also found that measurements of access
recirculation using a slow flow methodology were not predictive of
early graft thrombosis. These findings are in accord with recent
knowledge that the high recirculation rates measured in earlier
studies using peripheral vein cannulation for obtaining the sys-
temic sample overestimated access recirculation because of arte-
riovenous disequilibrium due to cardiopulmonary recirculation
[19]. It has recently been suggested that true dialysis access
recirculation is rare and correlates with the development of a
dialysis access flow rate that is below the prescribed treatment
blood flow rate [12]. An analysis by quartiles of the data from this
study did suggest that the highest recirculation quartile might be
associated with higher specificity of subsequent access thrombosis;
however, these results were also not statistically significant. It is
also possible that the blood flow rate (350 mI/mm) used in this
study to evaluate recirculation may not be high enough to induce
clinically significant recirculation.
It must be emphasized that the results of this study suggesting
that measurement of dialysis access flow is the best predictor of
early thrombosis is applicable only to PTFE grafts. Because
during the study period only 1 of the 48 patients with a functioning
autogenous arteriovenous fistula developed thrombosis, we could
not determine the relative efficacy of different screening tests in
this patient population. It has recently been suggested by others
that access blood flow may not be a good predictor of native
arteriovenous fistula thrombosis and that access recirculation may
0.5
0
1150 1050 1000 950 900 850 800 750 700 650 300 50
Access blood flow, mi/mm
Fig. 5. Relative risk of access thrombosis
within the subsequent 12 weeks by access blood
flow measured by ultrasound dilution technique
(P < 0.001 by multivariate analysis after
adjustment for other co-existing factors).
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still have a role as a screening test in patients with native
arteriovenous fistulae [10].
In summaly, we have prospectively evaluated the relative utility
of dialysis vascular access blood flow, as well as measurement of
percent urea recirculation and venous pressures during dialysis in
predicting early PTFE graft thrombosis in a large group of
patients in a multicenter study. Dialysis access blood flow has the
greatest utility for detecting early PTFE graft thrombosis. If
simple to use, cost-effective devices to measure dialysis access
blood flow become readily available, the measurement of access
blood flow will likely become the method of choice for screening
for vascular access dysfunction in hemodialysis patients.
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APPENDIX
Abbreviations used in this article are: CHD, chronic hemodialysis;
PTFE, polytetrafluoroethylene; AVF, arterio-venous fistulas; Qb, dialyzer
blood flow; URR, urea reduction ratio; BUN, blood urea nitrogen; Qac,
access flow; Kr, recirculation coefficient; Smix and Sven, areas under the
dilution curves generated by the arterial and venous sensors; GEE,
Generalized Estimating Equation.
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